Coherent Valuation

Is H7B undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of H7B when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: H7B (€100.5) is trading below our estimate of fair value (€151.47)

Significantly Below Fair Value: H7B is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for H7B?

Key metric: As H7B is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for H7B. This is calculated by dividing H7B's market cap by their current revenue.
What is H7B's PS Ratio?
PS Ratio3.3x
SalesUS$5.00b
Market CapUS$16.29b

Price to Sales Ratio vs Peers

How does H7B's PS Ratio compare to its peers?

The above table shows the PS ratio for H7B vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average3.4x
H2A H2APEX Group
6.4x34.1%€201.8m
JEN Jenoptik
1.1x4.4%€1.2b
300433 Lens Technology
1.5x15.3%CN¥99.6b
002179 Jonhon Optronic Technology
4.5x22.2%CN¥84.0b
H7B Coherent
3.3x10.9%€16.3b

Price-To-Sales vs Peers: H7B is good value based on its Price-To-Sales Ratio (3.3x) compared to the peer average (3.4x).


Price to Sales Ratio vs Industry

How does H7B's PS Ratio compare vs other companies in the DE Electronic Industry?

5 CompaniesPrice / SalesEstimated GrowthMarket Cap
SCE Schweizer Electronic
0.08x4.3%US$11.78m
IS7 InTiCa Systems
0.08x7.0%US$6.95m
UDC UniDevice
0.004x4.6%US$1.94m
7PF0 Syncro Group
0.02xn/aUS$341.17k
H7B 3.3xIndustry Avg. 0.9xNo. of Companies5PS00.40.81.21.62+
5 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: H7B is expensive based on its Price-To-Sales Ratio (3.3x) compared to the European Electronic industry average (0.9x).


Price to Sales Ratio vs Fair Ratio

What is H7B's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

H7B PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio3.3x
Fair PS Ratio1.3x

Price-To-Sales vs Fair Ratio: H7B is expensive based on its Price-To-Sales Ratio (3.3x) compared to the estimated Fair Price-To-Sales Ratio (1.3x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst H7B forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€100.50
€103.89
+3.4%
15.1%€129.04€56.93n/a17
Nov ’25€84.20
€85.71
+1.8%
17.0%€110.74€46.14n/a16
Oct ’25€79.40
€76.96
-3.1%
15.6%€108.41€45.17n/a16
Sep ’25€69.80
€74.32
+6.5%
11.8%€85.39€44.94n/a16
Aug ’25€64.20
€64.52
+0.5%
14.3%€82.30€41.15n/a16
Jul ’25€67.00
€63.89
-4.6%
13.8%€79.42€42.05n/a16
Jun ’25€54.20
€63.05
+16.3%
12.7%€72.59€41.88n/a16
May ’25€51.60
€62.15
+20.4%
12.4%€71.69€41.90n/a17
Apr ’25€57.00
€62.15
+9.0%
12.4%€71.69€41.90n/a17
Mar ’25€58.00
€60.86
+4.9%
11.6%€70.54€41.76n/a17
Feb ’25€43.80
€43.76
-0.09%
15.8%€57.83€32.13n/a17
Jan ’25€40.80
€41.66
+2.1%
15.7%€57.20€31.78n/a17
Dec ’24€33.20
€39.41
+18.7%
15.5%€57.35€31.86n/a17
Nov ’24€27.80
€40.46
+45.5%
16.3%€59.36€32.98€84.2016
Oct ’24€30.60
€38.27
+25.1%
16.9%€57.93€32.18€79.4016
Sep ’24€34.60
€38.27
+10.6%
16.9%€57.93€32.18€69.8016
Aug ’24€42.80
€46.03
+7.6%
23.6%€76.91€36.19€64.2016
Jul ’24€43.80
€42.27
-3.5%
28.3%€77.89€26.58€67.0016
Jun ’24€34.40
€38.77
+12.7%
28.5%€78.93€26.93€54.2016
May ’24€30.60
€52.14
+70.4%
31.4%€106.94€32.63€51.6016
Apr ’24€34.40
€56.06
+63.0%
30.4%€109.98€33.55€57.0017
Mar ’24€40.80
€56.14
+37.6%
30.5%€109.92€33.53€58.0017
Feb ’24€39.60
€55.53
+40.2%
33.4%€107.42€32.77€43.8017
Jan ’24€32.20
€58.28
+81.0%
33.9%€111.14€28.26€40.8016
Dec ’23€35.80
€61.16
+70.8%
33.9%€112.10€28.50€33.2016
Nov ’23€33.60
€71.31
+112.2%
33.0%€119.52€30.39€27.8015

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies